The FDA has approved uridine triacetate (Vistogard) to treat overdoses of the chemotherapy drugs fluorouracil and capecitabine and to treat severe, early-onset toxicities occurring with correct doses of these agents, the agency announced Friday.
The FDA has approved uridine triacetate (Vistogard) to treat overdoses of the chemotherapy drugs fluorouracil and capecitabine and to treat severe, early-onset toxicities occurring with correct doses of these agents, the agency announced Friday.